Literature DB >> 9649164

Prostate-specific antigen in the cerebrospinal fluid leads to diagnosis of solitary cauda equina metastasis: a unique case report and review of the literature.

B Schaller1, A Merlo, E Kirsch, K Lehmann, P R Huber, P Lyrer, A J Steck, O Gratzl.   

Abstract

A 79-year-old male patient presented with a subacute cauda syndrome caused by an intradural metastasis of the lumbosacral caudate fibres from an adenocarcinoma of the prostate, which had been treated 5 years earlier with external beam radiation therapy. Diagnosis could not be established by repeated magnetic resonance images (MRIs) during a 2-year period of increasingly severe radicular pain. Eventually, a small tumour mass could be visualized on the fourth MRI. Repeated normal serum prostate-specific antigen (PSA) did not hint at a prostate cancer metastasis (range 2.4-5.1 ng ml(-1)); however, PSA in the cerebrospinal fluid was found to be elevated (29.1 ng ml(-1)). Empirical radiation therapy of the caudate region did not improve radicular pain. Therefore, an exploratory surgical procedure was conducted, which confirmed the suspicion of an intradural prostate cancer metastasis. In conclusion, PSA in the cerebrospinal fluid provides a useful diagnostic tool for detecting intradural prostate cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649164      PMCID: PMC2150374          DOI: 10.1038/bjc.1998.397

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Metastases from cancer of the prostate; autopsy and roentgenological findings.

Authors:  M ELKIN; H P MUELLER
Journal:  Cancer       Date:  1954-11       Impact factor: 6.860

Review 2.  The surgical treatment of metastatic spinal tumors within the intradural extramedullary compartment.

Authors:  T S Chow; I E McCutcheon
Journal:  J Neurosurg       Date:  1996-08       Impact factor: 5.115

3.  Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study.

Authors:  M E Olson; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1974-02

4.  Classification of prostatic carcinomas.

Authors:  D F Gleason
Journal:  Cancer Chemother Rep       Date:  1966-03

5.  MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis.

Authors:  G Sze; S Soletsky; R Bronen; G Krol
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

6.  Clinical outcome in aggressively treated meningeal carcinomatosis.

Authors:  R Grant; B Naylor; H S Greenberg; L Junck
Journal:  Arch Neurol       Date:  1994-05

7.  Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study.

Authors:  T Siegal; U Sandbank; A Gabizon; T Siegal; R Mizrachi; E Ben-David; R Catane
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

8.  Meningeal carcinomatosis: CSF cytology, immunocytochemistry and biochemical tumor markers.

Authors:  P Oschmann; M Kaps; J Völker; W Dorndorf
Journal:  Acta Neurol Scand       Date:  1994-05       Impact factor: 3.209

9.  Gadolinium-DTPA in the evaluation of intradural extramedullary spinal disease.

Authors:  G Sze; A Abramson; G Krol; D Liu; J Amster; R D Zimmerman; M D Deck
Journal:  AJR Am J Roentgenol       Date:  1988-04       Impact factor: 3.959

10.  In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin.

Authors:  P R Huber; G Mattarelli; B Strittmatter; G J van Steenbrugge; H P Schmid; A Maurer
Journal:  Prostate       Date:  1995-09       Impact factor: 4.104

View more
  9 in total

1.  Cerebrospinal fluid prostate specific antigen (CSF PSA) in prostate cancer patients with lower spine metastasis.

Authors:  Hayrettin Sahin; Uğur Aflay; Sabri Batun; Mehmet Kamuran Bircan
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 2.  Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.

Authors:  Gabrielle Mangin; Nathalie Kubis
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 3.  Leptomeningeal metastases from prostate cancer: an emerging clinical conundrum.

Authors:  George Orphanos; Alexandros Ardavanis
Journal:  Clin Exp Metastasis       Date:  2009-11-11       Impact factor: 5.150

4.  Cauda equina syndrome caused by isolated spinal extramedullary-intradural cauda equina metastasis is the primary symptom of small cell lung cancer: a case report and review of the literatrure.

Authors:  Jian Xiong; Peixun Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  Prostate-specific antigen in the cerebrospinal fluid: a marker of local disease.

Authors:  George Orphanos; George Ioannidis; Michael Michael; George Kitrou
Journal:  Med Oncol       Date:  2008-10-02       Impact factor: 3.064

6.  Intramedullary spinal cord metastasis from prostate carcinoma: a case report.

Authors:  Robert E Lieberson; Anand Veeravagu; Jan M Eckermann; James R Doty; Bowen Jiang; Russell Andrews; Steven D Chang
Journal:  J Med Case Rep       Date:  2012-06-01

7.  The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis.

Authors:  Leyuan Zang; Min Ma; Jianxin Hu; Hao Qiu; Bo Huang; Tongwei Chu
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

8.  Therapeutic implications of osteoprotegerin.

Authors:  Sofia Fili; Maria Karalaki; Bernhard Schaller
Journal:  Cancer Cell Int       Date:  2009-09-12       Impact factor: 5.722

9.  Intracranial metastasis from prostate adenocarcinoma: a case report and literature review.

Authors:  Suhu Liu; Ahmed Hassaan Qavi; Yoel Kim; Prasanta Basak; Stephen Jesmajian
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.